CANADA CA2601784, the compound patent for semaglutide in Canada, was scheduled to expire in March 2026, however, due to Novo Nordisks failure to pay the required maintenance fees, the patent has lapsed and Novo Nordisk's market exclusivity for semaglutide in Canada officially ended on January 4, 2026
For instance, Wegovy s safety and efficacy were studied in four 68-week trials
In severe cases, nerve damage may become irreversible, making early intervention a priority for maintaining hand health
If such an association were found, it would be a red flag that the treatment and comparison groups are different for reasons that dont have to do with GLP-1 drugs (but they found NO association with traffic accidents, so no red flag)
With the power of Quicksilver Delivery Systems, Quicksilver's Liposomal Glutathione rivals IV replenishment with unsurpassed oral absorption of this universal antioxidant.*
If needed, you can keep unopened Humalog products at a room temperature no higher than 86F (30C)
